Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

Individuality, Unique, Unswerving, Steady. Green correct check mark among many red wrong or cross icon on wooden circle for true or false changing mindset. Not changing or becoming weaker.

Gene therapy

FDA Restricts Patient Pool for Bluebird’s Skysona Amid Safety Concerns

Skysona can now only be used in patients with cerebral adrenoleukodystrophy who have no available treatment alternatives or stem cell donors.

August 11, 2025

2 min read

Tristan Manalac

Concept of application new technology in future medicine

IN PARTNERSHIP WITH TOZARO

The Future of Cell and Gene Therapy: Navigating Innovation, Regulation, and Manufacturing Challenges

An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), reveals both promising developments and significant concerns shaping the advanced therapies sector’s trajectory through 2025 and beyond. This interview was conducted with support from Tozaro.

August 11, 2025

8 min read

BioSpace Insights

The mRNA strand carries genetic code. Cellular translation process. A ribosome synthesizes protein based on mRNA information. The ribosome decodes mRNA to form a protein chain. Molecular biology 3D illustration

Opinion

Opinion: Antagonism to mRNA Technology Is Killing Our Best Shot at a Cure for Cancer

The recent announcement of RFK Jr.’s termination of mRNA vaccine contracts is the latest effort to undermine this promising technology at the federal level. Pharmaceutical companies and private investors must fill the gap and ensure that research into this critical resource continues.

August 11, 2025

6 min read

Jonathan Kagan, PhD

Composite photo collage of human doctor hand wear glove hold corona pandemic biohazard illness diagnostics isolated on painted background.

Gene therapy

Sarepta’s Woes Put the Stalwart AAV Under a Harsh Light

In the wake of multiple patient deaths from liver injuries related to Sarepta Therapeutics’ AAV gene therapy platform, some in the sector are looking for ways to improve the current technology, while others are eager to move on.

August 11, 2025

7 min read

Dan Samorodnitsky

GLP-1 injector pens and pills against colorful background

Obesity

5 Oral Obesity Drugs Challenging Lilly’s Orforglipron

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

August 11, 2025

10 min read

Tristan Manalac

A scientist with pill bottles in front of FDA headquarters

FDA

FDA Action Alert: Biogen/Eisai, Sanofi, Ionis and More

Arguably the FDA’s most anticipated decision this month is for a subcutaneous induction formulation of Biogen and Eisai’s Alzheimer’s drug Leqembi, which, according to Eisai, could “help reduce the burden on healthcare professionals and patients.”

August 11, 2025

5 min read

Tristan Manalac

FDA

Prasad Back at CBER After 10-Day California ‘Vacation’

After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for Biologics Evaluation and Research, HHS confirmed to several outlets Saturday.

August 9, 2025

2 min read

Heather McKenzie

medical laboratory equipment. robotic drug packaging.

Manufacturing

FDA Launches New PreCheck Program To Lower Regulatory Barriers to Pharma Manufacturing

Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or expand manufacturing sites in the U.S.

August 8, 2025

2 min read

Tristan Manalac